Company Filing History:
Years Active: 2025
Title: Innovations by Jonathan M Carlson in Lyme Disease Research
Introduction
Jonathan M Carlson is an accomplished inventor based in Redmond, WA (US). He has made significant contributions to the field of medical research, particularly in the area of Lyme disease. His innovative work focuses on T cell receptor-related methods that can aid in the assessment and treatment of this condition.
Latest Patents
Jonathan holds a patent for "Lyme disease-associated T cell receptor-related methods." This patent provides methods for assessing T cell receptor β chain complementary determining region 3 (TCRβ CDR3) sequences. The methods involve evaluating TCRβ CDR3 sequences from samples obtained from subjects who have or are suspected of having a tick bite. This assessment can identify the presence or absence of specific TCRβ CDR3 sequences. Notably, these methods can be applied even when the subject is seronegative for Lyme disease and exhibits non-specific symptoms consistent with the disease. Furthermore, the patent includes methods for administering Lyme disease therapy to subjects identified as having T cells that express a TCRβ comprising the specified TCRβ CDR3 sequence.
Career Highlights
Jonathan is associated with Adaptive Biotechnologies Corporation, where he continues to advance his research and innovations. His work is pivotal in developing new diagnostic and therapeutic approaches for Lyme disease, showcasing his commitment to improving patient outcomes.
Collaborations
Jonathan collaborates with notable colleagues, including Harlan Saul Robins and Thomas M Snyder. Their combined expertise enhances the research efforts at Adaptive Biotechnologies Corporation, fostering an environment of innovation and discovery.
Conclusion
Jonathan M Carlson's contributions to Lyme disease research through his patented methods exemplify the impact of innovative thinking in medical science. His work not only advances our understanding of the disease but also paves the way for improved diagnostic and therapeutic strategies.